Medtronic plc (MDT) operating KPIs
MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value
$96.54−0.57 (-0.59%)
Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%
Medtronic neuroscience Portfolio — Organic Revenue Growth YoY (%) (%)
Medtronic Form 8-K World-Wide Revenue Tables (Published Organic Growth)
Latest, FY2026
3.1%
Period ended Apr 30, 2026
Change on a year earlier
-2.1 pts
5.2% in FY2025
History
6 years
Since FY2021
Sources
6
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Neuroscience Portfolio — Organic Revenue Growth YoY (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2026 | Apr 30, 2026 | 3.1% | -2.1 pts | Medtronic SEC 8K_EARNINGS — FY2026Q4 (filed 2026-06-03) ↗ |
| FY2025 | Apr 30, 2025 | 5.2% | 0.0 pts | Medtronic SEC 8K_EARNINGS — FY2025Q4 (filed 2025-05-21) ↗ |
| FY2024 | Apr 30, 2024 | 5.2% | +1.1 pts | Medtronic SEC 8K_EARNINGS — FY2024Q4 (filed 2024-05-23) ↗ |
| FY2023 | Apr 30, 2023 | 4.1% | -3.1 pts | Medtronic SEC 8K_EARNINGS — FY2023Q4 (filed 2023-05-25) ↗ |
| FY2022 | Apr 30, 2022 | 7.2% | +2.1 pts | Medtronic SEC 8K_EARNINGS — FY2022Q4 (filed 2022-05-26) ↗ |
| FY2021 | Apr 30, 2021 | 5.1% | – | Medtronic SEC 8K_EARNINGS — FY2021Q4 (filed 2021-05-27) ↗ |
Cite this data
StockData. (2026). Medtronic Neuroscience Portfolio — Organic Revenue Growth YoY (%) (%), annual FY2021–FY2026 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/neuro-port-ww-org
See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.